Skip to content
Platform
Programs
People
News
Join Us
Contact Us
Menu
Platform
Programs
People
News
ALTA2618
August 22, 2024
More
January 15, 2025
Imagenomix Corp. Partners with Alterome Therapeutics Inc. to Enhance Precision Oncology Clinical Trials with AI
October 30, 2024
Alterome Therapeutics Announces First Patient Dosed in Phase 1 Study of ALTA2618 in AKT1 E17K-mutant solid tumors (AKTive-001)